BIO — Bioton SA Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapNeutral
- PLN346.89m
- PLN433.39m
- PLN163.03m
- 37
- 47
- 20
- 24
Annual cashflow statement for Bioton SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
C2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.1 | 26.1 | -127 | 33.9 | 2.88 |
| Depreciation | |||||
| Non-Cash Items | 3.48 | -58.6 | 149 | 6.53 | 2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -15.2 | 30.9 | -7.55 | -30.2 | -31 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.62 | 27.9 | 46.7 | 41.9 | 5.52 |
| Capital Expenditures | -17.8 | -43.4 | -53.5 | -4.68 | -12.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 8.74 | 80.9 | -0.345 | -0.001 | 8.61 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -9.04 | 37.5 | -53.8 | -4.68 | -4.28 |
| Financing Cash Flow Items | -10.2 | -6.71 | -6.41 | -1.26 | -3.78 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -43.8 | -96.3 | 6.53 | -22.2 | -14.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -51.2 | -30.9 | -0.568 | 15.1 | -13.4 |